TMEM229A Activators
TMEM229A Activators are a diverse set of chemical compounds that indirectly promote the activity of TMEM229A through intricate intracellular signaling cascades and the modulation of cellular environments. For instance, Forskolin and 8-CPT-cAMP both amplify the intracellular levels of cAMP, a secondary messenger that activates PKA. This activation can result in the phosphorylation of proteins associated with the cellular membrane, such as TMEM229A, potentially enhancing its function. Moreover, Ionomycin and Thapsigargin both elevate intracellular calcium levels, a critical factor that can trigger various calcium-dependent signaling pathways influencing TMEM229A activity. Similarly, PMA mimics the action of diacylglycerol, activating PKC which, through its phosphorylation targets, may promote TMEM229A's role in cellular processes. Brefeldin A, by disrupting Golgi function, may affect the trafficking and localization of TMEM229A, while Manumycin A, by inhibiting farnesyltransferase, could influence RAS-related pathways, potentiallyleading to TMEM229A activation.
The functional dynamics of TMEM229A are further influenced by chemicals that disrupt normal protein and ion homeostasis within the cell. Nigericin, through its potassium ionophore activity, and Monensin, as a disruptor of sodium and proton gradients, can potentially create an ionic environment conducive to the modulation of TMEM229A activity. Jasplakinolide's ability to stabilize actin filaments might indirectly impact TMEM229A by modifying its interaction with the cytoskeleton, affecting its cellular context and functionality. Okadaic Acid, by inhibiting protein phosphatases, could lead to a heightened state of protein phosphorylation, indirectly affecting TMEM229A's activity by altering its phosphorylation status. Chelerythrine, although typically a PKC inhibitor, could induce a compensatory response in cellular signaling pathways, leading to the enhanced function of TMEM229A through alternative routes. Collectively, these TMEM229A Activators, through targeted effects on cellular signaling and environment, facilitate the enhancement of TMEM229A-mediated functions without the need for upregulating its expression or direct activation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is an inhibitor of ADP-ribosylation factor (ARF), which is a small GTPase involved in vesicle trafficking. By inhibiting ARF, Brefeldin A disrupts Golgi structure and function, potentially affecting the intracellular trafficking and localization of TMEM229A, leading to its functional upregulation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels within cells. Elevated cAMP activates PKA (protein kinase A), which can phosphorylate various proteins and influence membrane-associated proteins like TMEM229A, potentially leading to its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate various calcium-dependent signaling pathways, which may influence the activity and function of membrane proteins such as TMEM229A. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol (DAG) analog that activates protein kinase C (PKC). Activated PKC phosphorylates target proteins, which may include TMEM229A or other proteins in its pathway, enhancing its cellular function. | ||||||
8-CPT-cAMP | 93882-12-3 | sc-201569 sc-201569A | 20 mg 100 mg | $87.00 $316.00 | 19 | |
8-CPT-cAMP is a cAMP analog resistant to phosphodiesterase degradation, leading to prolonged PKA activation. This sustained PKA activity can enhance the phosphorylation and functionality of membrane proteins, including TMEM229A. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Manumycin A is an inhibitor of farnesyltransferase, an enzyme involved in the post-translational modification of small GTPases. By inhibiting this modification, Manumycin A could affect cellular signaling pathways, potentially leading to the enhancement of TMEM229A activity. | ||||||
Nigericin sodium salt | 28643-80-3 | sc-201518A sc-201518 sc-201518B sc-201518C sc-201518D | 1 mg 5 mg 25 mg 1 g 5 g | $46.00 $112.00 $240.00 $7079.00 $27417.00 | 9 | |
Nigericin is a potassium ionophore that alters intracellular potassium levels, potentially modulating the cellular environment and affecting the activity of membrane proteins like TMEM229A. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and can lead to changes in cell morphology and signaling. This may indirectly impact the functionality of membrane proteins including TMEM229A by altering their cellular context. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts sodium and proton gradients across cellular membranes. This disruption can modulate the activity of sodium-sensitive pathways and potentially enhance the function of membrane proteins such as TMEM229A. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins. This can indirectly affect the activity of TMEM229A by modulating its phosphorylation state. | ||||||